Evaluating the Anion Gap's Role in Predicting Mortality in Acute Pulmonary Embolism
The Prognostic Value of Anion Gap in Predicting Mortality Among Patients With Acute Pulmonary Embolism
This study is trying to see if the anion gap can help predict the risk of death in patients with acute pulmonary embolism.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 20 (estimated) |
| Ages | 18 Years to 70 Years |
| Sex | All |
| Sponsor | Universitas Diponegoro Academic / other |
| Locations | 1 site (Semarang, Central of Java) |
| Trial ID | NCT06583616 on ClinicalTrials.gov |
What this trial studies
This observational study aims to assess how the anion gap can predict mortality in patients diagnosed with acute pulmonary embolism. Researchers will gather secondary data from hospital registries, focusing on patients who have undergone CT scans for diagnosis. The study will analyze demographic information, clinical presentations, laboratory results, and CT scan findings using IBM SPSS Statistics v26 to determine the prognostic value of the anion gap. This approach seeks to enhance understanding of mortality risks associated with acute pulmonary embolism.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 to 70 who have been diagnosed with acute pulmonary embolism.
Not a fit: Patients with a history of heart failure, valvular heart disease, chronic obstructive pulmonary disease, congenital heart disease, sepsis, or chronic kidney disease may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into mortality risk assessment for patients with acute pulmonary embolism, potentially guiding clinical decision-making.
How similar studies have performed: While the specific prognostic value of the anion gap in acute pulmonary embolism may be novel, similar studies have explored mortality predictors in other conditions, indicating potential for success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * age: 18 - 70 years old * patient with acute pulmonary embolism Exclusion Criteria -- patient with history of: * heart failure * valvular heart disease * chronic obstructive pulmonary disease * congenital heart disease * sepsis * chronic kidney disease
Where this trial is running
Semarang, Central of Java
- Dr. Kariadi Central General Hospital — Semarang, Central of Java, Indonesia (Recruiting)
Study contacts
- Study coordinator: Leo Deddy Pradipta, MD
- Email: dancingdeagle@gmail.com
- Phone: +6281316499074
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.